MedEsthetics Jan/Feb 2019
An annual marketing plan is key to achieving your practice growth goals: Here’s how to create one.

New Year’s resolutions are made with the best of intentions. We begin with determination, but get distracted or busy and gradually revert to our old familiar ways. Next thing you know, the resolution is long forgotten.

In the world of business, New Year’s resolutions translate into the objectives or goals you wish your medical practice to accomplish in the coming year. Perhaps it is seeing your...

Articles

MedEsthetics Jan/Feb 2019

New Year’s resolutions are made with the best of intentions. We begin with...

MedEsthetics Jan/Feb 2019

Informed consent—the idea that patients have the right to make their own decisions...

MedEsthetics Jan/Feb 2019

In a tight labor market employers must use every tool at their disposal to land the...

MedEsthetics Cover Profile Nov/Dec 2018

Urmen Desai, MD, learned at an early age the rewards of caring for others. His parents...

Products

Handheld Body Imaging System for Aesthetics

Canfield Scientific’s VECTRA H2 offers an all-in-one portable lightweight 3D...

Hydrating and Correcting Lip Treatment

Topix Pharmaceuticals' Replenix Pure Hydration Plumping Lip Treatment Broad...

Fotofinder Automated ABTM

Capture consistent before-and-after images with FotoFinder’s new Automated...

Skin Care for Eczema

Epionce Renewal Calming Cream from Episciences soothes sensitive, eczema-...

NEWS

Dermal Fillers
Tiffany J. Libby, MD, et al, surveyed members of the American Society of Dermatologic Surgery (ASDS) to determine how often they mix injectable fillers with other substances and which solutions are most commonly added to the fillers prior to injection. Four hundred seventy-five dermatologists...
Seysara approved for acne
Almirall’s Seysara (sarecycline), a novel tetracycline-derived oral antibiotic developed specifically for the treatment of acne, is now commercially available in the United States. Seysara was approved in October 2018 by the U.S. Food and Drug Administration (FDA) for the treatment of moderate...
One Third of Dermatologists Mix Injectable Fillers Prior to Injection

Tiffany J. Libby, MD, et al, surveyed members of the American Society of Dermatologic Surgery (ASDS) to determine how often they mix injectable fillers with other substances and which solutions are most commonly added to the fillers prior to injection.

Four hundred seventy-five dermatologists responded, and 35 percent of respondents reported that they mix fillers before injection. Solutions added to the fillers include: plain lidocaine (44 percent), lidocaine with epinephrine (36 percent), normal saline (30 percent) and sterile water (7 percent). The reasons for mixing include: to decrease viscosity (40 percent), increase anesthesia (30 percent), decrease swelling (17 percent) and increase volume (13 percent).

The results of the survey were published in the January 2019 issue of Dermatologic Surgery.

Image copyright Getty Images

New Oral Antibiotic For Acne Now Available

Almirall’s Seysara (sarecycline), a novel tetracycline-derived oral antibiotic developed specifically for the treatment of acne, is now commercially available in the United States. Seysara was approved in October 2018 by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe non-nodular inflammatory acne vulgaris in patients 9 years of age and older.

In the two identical Phase 3 clinical trials (SC1401 and SC1402), a significant number of patients receiving once-daily Seysara experienced improvement of their acne severity at 12 weeks versus placebo based on the Investigator’s Global Assessment (IGA) (21.9% vs. 10.1% SC1401; 22.6% vs. 15.3% SC1402). Seysara also led to a reduction in the number of inflammatory acne lesions at 12 weeks (51.8% vs. 35.1% SC1401; 49.9% vs.35.4% SC1402), with significant results seen as early as week 3 (29.6% vs. 22.4% SC1401; 28% vs. 18.6% S1402).

Seysara was found to be generally safe and well tolerated. Less than one percent of patients experienced photosensitivity or sunburn. The most common adverse reaction (incidence ≥ 1%) was nausea.

“Unlike most other pivotal acne studies, the Seysara trials analyzed the impact of the study drug on chest and...

Real Housewife Sonja Morgan Is New Face of CoolSculpting

Television personality Sonja Morgan of Bravo’s “The Real Housewives of New York City” is partnering with CoolSculpting (owned by Allergan) as the face of the brand's latest “Let’s Get Real About Self-Care” campaign. Morgan will share her self-care tips as well as her own personal CoolSculpting story in marketing materials, digital advertising and on CoolSculpting social channels. In addition, she will participate in public relations activities.

“I’m thrilled to be partnering with CoolSculpting and to talk honestly about taking the time to care for oneself,” said Morgan. “I’m proud of the body I have at my age, and I work hard to stay active and healthy. But sometimes, one may want a little extra help. For me, CoolSculpting is the perfect complement to my existing self-care routine! It helps me look good on-and-off camera.”

Through various media channels and at an in-person event with dermatologist Daniel Belkin, MD, in New York City on March 20, Morgan will share her self-care journey with fans and discuss her top beauty and wellness tips—from how she preps for red carpet moments in her own life to how she battles bikini denial.

“We’re incredibly excited to have Sonja Morgan as the face of our ‘Let’s Get...

ASDS Honored With 14 MarCom Awards

The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.


The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.


The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »

Cellfina Available in US

Merz Aesthetics has begun commercial shipment of the Cellfina System, indicated for long-term improvement in the appearance of cellulite in the buttocks and thighs, to aesthetic practices in the U.S.


Cellfina combines proprietary technology with minimally invasive subcision to treat the primary structural cause of dimpled cellulite. Results of the procedure last at least two years—in clinical trials, patient satisfaction with their treatment results improved from 94% at one year to 96% at the two-year mark. The most common side effects reported were soreness, tenderness and bruising... more »

This Issue - January/February 2016